Sponsorships & Exhibitions
About This Event
Advancing research and therapies for GBA1-associated disorders
GBA1
Meeting 2026:
Striving for a better future for all those affected by neurodegenerative diseases
Small molecules targeting GBA1
Population-based studies informing GBA1 strategies
Clinical considerations in GBA1 neurodegeneration
Gain vs. loss of function mechanisms in GBA1
Gene and cell therapy for GBA1-associated disease
Secure your seat at the premier event
Discover the program of the event
Event Information
Why you should Join Our Event
Following the success of last year’s inaugural meeting, we are pleased to host the GBA1 Scientific Meeting 2026 — a gathering of leading experts, researchers, and industry partners in the field of GBA1-associated disorders.”
Cutting-Edge Research & Breakthroughs.
Attend exclusive presentations showcasing the latest discoveries in GBA1 biology, Parkinson’s disease mechanisms, and therapeutic development—including unpublished data from leading laboratories worldwide.
Unmatched Networking With Global Experts.
Connect directly with clinicians, geneticists, neuroscientists, industry partners, and patient-advocacy leaders working specifically on GBA1-associated disorders. Build collaborations that can accelerate your research and clinical impact.
Translational Impact & Future Therapies.
Learn how GBA1 research is transforming drug discovery and precision medicine. Engage in discussions on ongoing clinical trials, emerging biomarkers, and therapeutic pipelines from academia and biotech.
Community, Collaboration & Growth.
Be part of the largest international GBA1-focused scientific community, fostering open science, shared resources, and collective problem-solving to improve outcomes for patients affected by GBA1-related conditions.
our location
Where the Meeting Happens: Renaissance Phoenix Downtown Hotel
This hotel is also the official conference accommodation, offering easy access to all meeting sessions and networking events. Attendees are encouraged to book their stay early to secure preferred rates and ensure proximity to the conference activities.
Learn more
Our Official Sponsors
Thank you to all our sponsors
What they are saying
Attendee reflections
“Having patients with PD and with Gaucher in the room was extremely inspiring. Reminds us why we do what we do as researchers. All the efforts toward democratizing patient data, biomarker data in the spirit of open science is encouraging. Need organizations like MJFF and G-Can to work and partner closely with industry to promote this even more.”
“This is the most up-to-date GBA1 meeting as such it is the most informative with new information. Also, the attendees are mostly on top of all new developments in this field. It is the BEST GBA1 meeting”
“As both an oral and poster presenter, I gained invaluable direction for my next steps thanks to the expert comments received. The meeting also provided crucial insights into Parkinson's disease through the latest research findings. Additionally, I found the updates from other drug discovery companies incredibly stimulating, inspiring me to further intensify our efforts”
“This meeting is an important collaborative space to gain valuable cross-domain insights into the research and progress into characterizing and treating GBA-PD. It also provides the opportunity for new collaborations and ideas for the future. ”